| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Director
2 companies
Ajer Jeffrey Robert is an EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,004 | $89.61 | $89,968.44 | -2.1% | |
| May 5, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sale+OE | 4,486 | $99.00 | $444,114.00 | -4.2% | |
| May 2, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 302 | $96.74 | $29,215.48 | -0.6% | |
| Mar 29, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,890 | $89.15 | $346,793.50 | -7.0% | |
| Mar 7, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 5,000 | $90.56 | $452,800.00 | -9.7% | |
| Sep 27, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 18,467 | $95.61 | $1,765,648.34 | -30.9% |